相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。CanAssist Breast Impacting Clinical Treatment Decisions in Early-Stage HR plus Breast Cancer Patients: Indian Scenario
Satish Sankaran et al.
INDIAN JOURNAL OF SURGICAL ONCOLOGY (2021)
Impact of delayed treatment in women diagnosed with breast cancer: A population-based study
Peh Joo Ho et al.
CANCER MEDICINE (2020)
CanAssist breast: An affordable breast cancer prognostic test validated on Asian patients.
Poonam Patil et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
MINDACT: Long-term results of the large prospective trial testing the 70-gene signature MammaPrint as guidance for adjuvant chemotherapy in breast cancer patients.
Fatima Cardoso et al.
JOURNAL OF CLINICAL ONCOLOGY (2020)
A multi-institutional real world data study from India of 3453 non-metastatic breast cancer patients undergoing upfront surgery
Dinesh Chandra Doval et al.
SCIENTIFIC REPORTS (2020)
Comparison of breast cancer prognostic tests CanAssist Breast and Oncotype DX
Aditya K. Sengupta et al.
CANCER MEDICINE (2020)
Implications of the 21-gene recurrence score assay (Oncotype DX) on adjuvant treatment decisions in ER-positive early-stage breast cancer patients: experience of Kuwait Cancer Control Center
Salah Fayaz et al.
JOURNAL OF THE EGYPTIAN NATIONAL CANCER INSTITUTE (2020)
Analytical validation of CanAssist-Breast: an immunohistochemistry based prognostic test for hormone receptor positive breast cancer patients
Arun Kumar Attuluri et al.
BMC CANCER (2019)
Clinical validation of an immunohistochemistry-based CanAssist-Breast test for distant recurrence prediction in hormone receptor-positive breast cancer patients
Manjiri M. Bakre et al.
CANCER MEDICINE (2019)
Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
F. Cardoso et al.
ANNALS OF ONCOLOGY (2019)
Treating HR+/HER2-breast cancer in premenopausal Asian women: Asian Breast Cancer Cooperative Group 2019 Consensus and position on ovarian suppression
Winnie Yeo et al.
BREAST CANCER RESEARCH AND TREATMENT (2019)
Clinical and Genomic Risk to Guide the Use of Adjuvant Therapy for Breast Cancer
Joseph A. Sparano et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Nomogram update based on TAILORx clinical trial results - Oncotype DX breast cancer recurrence score can be predicted using clinicopathologic data
Amila Orucevic et al.
BREAST (2019)
Role of Patient and Disease Factors in Adjuvant Systemic Therapy Decision Making for Early-Stage, Operable Breast Cancer: Update of the ASCO Endorsement of the Cancer Care Ontario Guideline
N. Lynn Henry et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Incorporating Tumor Characteristics to Maximize 21-Gene Assay Utility: A Cost-Effectiveness Analysis
Shi-Yi Wang et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2019)
Oncotype DX Breast Cancer recurrence score resists inter-assay reproducibility with RT2-Profiler Multiplex RT-PCR
Verena Schildgen et al.
SCIENTIFIC REPORTS (2019)
Impact of Pharmacogenomics on Clinical Outcomes for Patients Taking Medications With Gene-Drug Interactions in a Randomized Controlled Trial
Michael E. Thase et al.
JOURNAL OF CLINICAL PSYCHIATRY (2019)
Current Issues in the Overdiagnosis and Overtreatment of Breast Cancer
Debra L. Monticciolo et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2018)
Epidemiologic analysis of breast cancer incidence, prevalence, and mortality in India Protocol for a systematic review and meta-analyses
Madurantakam Royam Madhav et al.
MEDICINE (2018)
Practical consensus recommendations on management of HR
S. Aggarwal et al.
SOUTH ASIAN JOURNAL OF CANCER (2018)
Development of a Novel Proteomic Risk-Classifier for Prognostication of Patients With Early-Stage Hormone Receptor-Positive Breast Cancer
Charusheila Ramkumar et al.
BIOMARKER INSIGHTS (2018)
Epidemiology of breast cancer in Indian women
Shreshtha Malvia et al.
ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY (2017)
Breast cancer in young women: A retrospective study from tertiary care center of north India
Deepti Sharma et al.
SOUTH ASIAN JOURNAL OF CANCER (2017)
Absolute Benefit of Adjuvant Endocrine Therapies for Premenopausal Women With Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer: TEXT and SOFT Trials
Meredith M. Regan et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
70-Gene Signature as an Aid to Treatment Decisions in Early-Stage Breast Cancer
F. Cardoso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Delayed Initiation of Adjuvant Chemotherapy Among Patients With Breast Cancer
Mariana Chavez-MacGregor et al.
JAMA ONCOLOGY (2016)
Predictive value and clinical utility of centrally assessed ER, PgR, and Ki-67 to select adjuvant endocrine therapy for premenopausal women with hormone receptor-positive, HER2-negative early breast cancer: TEXT and SOFT trials
Meredith M. Regan et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Global surveillance of cancer survival 1995-2009: analysis of individual data for 25 676 887 patients from 279 population-based registries in 67 countries (CONCORD-2)
Claudia Allemani et al.
LANCET (2015)
The Predictive Accuracy of PREDICT: A Personalized Decision-Making Tool for Southeast Asian Women With Breast Cancer
Hoong-Seam Wong et al.
MEDICINE (2015)
Predicting and Communicating the Risk of Recurrence and Death in Women With Early-Stage Breast Cancer: A Systematic Review of Risk Prediction Models
Ellen G. Engelhardt et al.
JOURNAL OF CLINICAL ONCOLOGY (2014)
Delay to Curative Surgery Greater than 12 Weeks Is Associated with Increased Mortality in Patients with Colorectal and Breast Cancer but Not Lung or Thyroid Cancer
Dong Wook Shin et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Application of the Adjuvant! Online Model to Korean Breast Cancer Patients: An Assessment of Prognostic Accuracy and Development of an Alternative Prognostic Tool
Minkyu Jung et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Clinical Usefulness of AJCC Response Criteria for Neoadjuvant Chemotherapy in Breast Cancer
Bhumsuk Keam et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Breast Cancer Index Identifies Early-Stage Estrogen Receptor-Positive Breast Cancer Patients at Risk for Early- and Late-Distant Recurrence
Yi Zhang et al.
CLINICAL CANCER RESEARCH (2013)
Personalized medicine: Lung Cancer leads the way
P. Parikh et al.
INDIAN JOURNAL OF CANCER (2013)
Delay in Surgical Treatment and Survival After Breast Cancer Diagnosis in Young Women by Race/Ethnicity
Erlyn C. Smith et al.
JAMA SURGERY (2013)
Cost Effectiveness of Gene Expression Profiling for Early Stage Breast Cancer
Mo Yang et al.
CANCER (2012)
Adjuvant! Online is overoptimistic in predicting survival of Asian breast cancer patients
Nirmala Bhoo-Pathy et al.
EUROPEAN JOURNAL OF CANCER (2012)
Effect on Survival of Longer Intervals Between Confirmed Diagnosis and Treatment Initiation Among Low-Income Women With Breast Cancer
John M. McLaughlin et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
A New Molecular Predictor of Distant Recurrence in ER-Positive, HER2-Negative Breast Cancer Adds Independent Information to Conventional Clinical Risk Factors
Martin Filipits et al.
CLINICAL CANCER RESEARCH (2011)
The 70-Gene Prognostic Signature for Korean Breast Cancer Patients
Kuk Young Na et al.
JOURNAL OF BREAST CANCER (2011)
Epidemiological and clinical profile of breast cancer patients at a tertiary care hospital in South India
Prashant R. Kokiwar et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2011)
Can some patients avoid adjuvant chemotherapy for early-stage breast cancer?
Philippe L. Bedard et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
Delays in Time to Treatment and Survival Impact in Breast Cancer
Amy Brazda et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Clinical Utility of the 70-gene MammaPrint Profile in a Japanese Population
Makoto Ishitobi et al.
JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2010)
Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics
Matthew J. Ellis et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2008)
Spectrum of breast cancer in Asian women
Gaurav Agarwal et al.
WORLD JOURNAL OF SURGERY (2007)
Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival:: an overview of the randomised trials
O Abe et al.
LANCET (2005)
分享论文
